NVS: 诺华制药
今日NVS汇率已更改0.47%。当日,交易品种以低点147.44和高点149.11进行交易。
关注诺华制药动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
NVS新闻
- BIIB's Next-Gen SMA Therapy Salanersen Wins FDA's Breakthrough Tag
- FDA Accepts Vertex's BLA for Povetacicept in IgA Nephropathy
- Novartis: H2 Pipeline Readouts Matter, But Valuation Leaves Limited Upside (NYSE:NVS)
- AbbVie (ABBV) Up 3.5% Since Last Earnings Report: Can It Continue?
- AstraZeneca Stock: 8% Q1 Revenue Growth And Imfinzi/Ultomiris Trial Data Wins (NYSE:AZN)
- 3 Vanguard Dividend ETFs to Boost Passive Income in 2026 - TipRanks.com
- This AI Biotech Stock Landed a $10.4 Million Nvidia Investment
- Tectonic Therapeutics: Currently In A Catalyst Vacuum (NASDAQ:TECX)
- This Biotech's Drug Just Wiped The Floor With Forecasts
- Cancer Stocks That Are Advancing the Future of Oncology Care
- Implied Volatility Surging for Novartis Stock Options
- Arvinas: FDA Approval Validates The Platform, But Does Not Signal Near-Term Profitability
- Tempus AI: My Pick For An Oncoming Boom In Demand For Data-Driven Precision Medicine (TEM)
- This Small Biotech — Taking On AbbVie, Novartis And Sanofi — Just Catapulted Into A Breakout
- Alnylam Q1 Earnings Beat Estimates, Amvuttra Sales Drive Y/Y Growth
- Stock Market Rallies To New Highs; Apple, Google, Amazon, Sandisk, Powell In Focus: Weekly Review
- PTC Therapeutics Stock Sinks As Pivotal Data Fails To Calm Sellers - PTC Therapeutics (NASDAQ:PTCT)
- Novartis: Revenue Lags In Q1, Outlook Unchanged (NYSE:NVS)
- LLY Expands Oncology Pipeline With $2.3B Ajax Therapeutics Acquisition
- INCY Q1 Earnings and Revenues Beat Estimates on Higher Product Sales
- Novartis Q1 Earnings & Revenues Miss Estimates, Stock Down
- Novartis (NVS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
- Novartis Yo-Yoes As Generics Take A Bite Out Of Its First-Quarter Sales
- Novartis (NVS) CEO Warns Trump Drug Pricing Policy Could Hit Global Access as Earnings Slip - TipRanks.com
常见问题解答
NVS股票今天的价格是多少?
诺华制药股票今天的定价为149.09。它在147.44 - 149.11范围内交易,昨天的收盘价为148.39,交易量达到7305。NVS的实时价格图表显示了这些更新。
诺华制药股票是否支付股息?
诺华制药目前的价值为149.09。股息政策取决于公司,而投资者也会关注22.10%和USD。实时查看图表以跟踪NVS走势。
如何购买NVS股票?
您可以以149.09的当前价格购买诺华制药股票。订单通常设置在149.09或149.39附近,而7305和0.98%显示市场活动。立即关注NVS的实时图表更新。
如何投资NVS股票?
投资诺华制药需要考虑年度范围112.38 - 170.46和当前价格149.09。许多人在以149.09或149.39下订单之前,会比较1.47%和。实时查看NVS价格图表,了解每日变化。
诺华制药股票的最高价格是多少?
在过去一年中,诺华制药的最高价格是170.46。在112.38 - 170.46内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪诺华制药的绩效。
诺华制药股票的最低价格是多少?
诺华制药(NVS)的最低价格为112.38。将其与当前的149.09和112.38 - 170.46进行比较,可以发现潜在的长期切入点。观看NVS在图表上的实时走势以获取更多详细信息。
NVS股票是什么时候拆分的?
诺华制药历史上曾经历过股票拆分。这些变化在公司行动后的、148.39和22.10%中可见。
- 前一天收盘价
- 148.39
- 开盘价
- 147.64
- 卖价
- 149.09
- 买价
- 149.39
- 最低价
- 147.44
- 最高价
- 149.11
- 交易量
- 7.305 K
- 日变化
- 0.47%
- 月变化
- 1.47%
- 6个月变化
- 7.84%
- 年变化
- 22.10%
- 实际值
- 预测值
- 前值